Federal inspectors cited Avalon Villa Care Center on December 23 after discovering the facility failed to document informed consent from the responsible party before giving the powerful psychiatric drug to Resident 2.
The Quality Assurance Nurse told inspectors that the physician was responsible for explaining the risks and benefits of Depakote use and answering any questions the responsible party could have. The licensed nurse, she said, was responsible for verifying informed consent with the responsible party before administering Depakote to Resident 2.
But that verification never happened.
"By administering Depakote to Resident 2 without documentation informed consent was verified with RP 1, RP 1 may not be fully aware of the treatments given to Resident 2," the QA Nurse acknowledged to inspectors.
Depakote, known generically as divalproex sodium, is an antipsychotic medication used to treat bipolar disorder, seizures, and migraine headaches. The drug carries significant side effects and requires careful monitoring.
The facility's own policies, revised in July 2022, explicitly required informed consent for antipsychotic medications. The Antipsychotic Medication Use policy stated that "Residents and/or resident representatives will be informed of the recommendation, risks, benefits, purpose, and potential adverse consequences of antipsychotic medication use."
The policy was clear: "Residents and/or representatives may refuse medications of any kind."
A separate policy on Psychotropic Medication Use reinforced these requirements. It indicated that "Residents, families, and/or the representative are involved in the medication management process." This process includes explaining indications for use, dosing, duration, monitoring for effectiveness and adverse effects, and preventing and responding to negative consequences.
That policy also emphasized patient rights: "Residents and/or representatives have the right to decline treatment with psychotropic medications." When patients or families refuse medication, "The staff and physician will review the resident/representative the risks related to not taking the medication as well as appropriate alternatives."
None of this consultation appeared to happen before Depakote was given to Resident 2.
The violation occurred despite federal regulations requiring nursing homes to obtain informed consent before administering psychotropic medications. These drugs can cause serious side effects including drowsiness, confusion, tremors, weight gain, and liver problems. Some antipsychotics increase the risk of death in elderly patients with dementia.
The inspection was conducted in response to a complaint. Inspectors classified the violation as causing minimal harm or potential for actual harm, affecting few residents.
The failure to document informed consent means the facility cannot prove the responsible party understood what medication was being given, why it was prescribed, or what risks it carried. Without this documentation, families may remain unaware that their loved one is receiving powerful psychiatric medications that could significantly affect their behavior, cognition, and overall health.
Federal oversight of antipsychotic use in nursing homes has intensified in recent years after studies showed widespread inappropriate prescribing of these drugs to control behavior in dementia patients. The medications are often used as "chemical restraints" to sedate residents rather than address underlying causes of distress.
Proper informed consent serves as a critical safeguard, ensuring families understand both the potential benefits and serious risks before agreeing to treatment. When facilities skip this step, they deny families the opportunity to make truly informed decisions about their loved one's care.
The violation at Avalon Villa Care Center highlights how easily this protection can break down. Even when policies exist requiring informed consent, staff may fail to follow through, leaving vulnerable residents receiving powerful medications without their families' knowledge or understanding.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Avalon Villa Care Center from 2025-12-23 including all violations, facility responses, and corrective action plans.